Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA clears IntraLuminal's total occlusion guide wire:

This article was originally published in Clinica

Executive Summary

IntraLuminal Therapeutics has received US FDA 510(k) clearance to market the first of several generations of its total occlusion products, the Safe-Steer guide wire system. The product is designed to give the cardiologist real-time feedback as to the proximity of the crossing wire to the arterial wall. This should facilitate safe and successful passage through the total occlusion and placement of therapeutic catheters for recanalisation in native coronary arteries, says the Carlsbad, California firm. The market for products designed to cross and recanalise total occlusions is worth $1 billion, the company adds.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT065998

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel